Add BrightSurf on Google Email

University of Pennsylvania School of Medicine


Managed-Care

A nationwide review of managed-care companies' gatekeeping practices found nearly one-third of patients denied emergency medical care suffered adverse outcomes. The study highlights the need for in-person medical assessments, as telephone gatekeeping failed to reliably distinguish between safe and unsafe cases.

SourceUniversity of Pennsylvania School of Medicine·JournalAcademic Emergency Medicine·DateDec 2, 1997

Optimizing Working Memory: Effects Of Dopamine-Like Drug Enhances Short-Term Memory, Up To A Point

Researchers discover that dopamine levels can enhance or impair working memory, with a low dose of the drug bromocriptine improving scores in low-capacity subjects but worsening performance in high-capacity individuals. The study suggests an optimal level of dopamine for short-term memory to function properly.

The Two Sides Of Tobacco: Penn Researchers Discover Molecular Complexities Of Nicotine's Action

Researchers at the University of Pennsylvania Medical Center found that chronic exposure to nicotine stimulates and permanently inactivates two prominent subtypes of acetylcholine receptors, leading to tolerance. Habitual users become dependent on nicotine through neural reward pathways similar to other addictive drugs.

SourceUniversity of Pennsylvania School of Medicine·JournalJournal of Pharmacology and Experimental Therapeutics·DateNov 14, 1997

Two-Pronged Attack On Immune System Cells Engineered By HIV Gene vpr: Effects Markedly Reversed By Antisteroid Compound RU-486

Researchers found that HIV gene vpr blocks cytokine production in infected cells, preventing immune activation. Vpr also prevents apoptosis in infected cells but induces apoptosis in neighboring immune cells, making it harder for the body to defend against the infection. The antisteroid compound RU-486 reversed many of these effects.

Novel Death-Receptor Gene Identified: KILLER/DR5 Triggers Cancer Cell Death After Chemotherapy Or Radiation

Researchers at the University of Pennsylvania School of Medicine have identified a novel death-receptor gene called KILLER/DR5 that responds to chemotherapy and radiation by killing cancer cells. The discovery provides new insights into how cancer cells are killed after treatment, with potential implications for improving cancer therapy.

Molecular Architecture Of Genetic-Engineering Enzyme Revealed For First Time By Penn Researchers

A team of researchers at the University of Pennsylvania School of Medicine has determined the molecular structure of Cre recombinase, an enzyme used in genetically engineering animal models. The detailed structural picture will aid in designing better research models and provide insights into the recombination reaction.

Single Mechanism Seen To Underlie Group Of Neurodegenerative Diseases: Mutant Proteins Form Insoluble Masses In The Nuclei Of Neurons

Scientists have discovered a common mechanism underlying neurodegenerative diseases, where mutant proteins accumulate in nuclear spaces, recruiting normal proteins and disrupting cellular processes. This finding suggests a single disease mechanism may be responsible for several afflictions.

Multiple Genes Lead To Same Problem In Enlarged-Heart Disease Linked To Sudden Death In Athletes, New Study Shows

A new study has identified a common functional problem in enlarged heart disease that causes sudden death in athletes, regardless of the genetic cause. This finding suggests that a single therapeutic approach may be effective for all victims of hypertrophic cardiomyopathy (HCM), a leading cause of sudden death in young adults.